Cardiomyocyte senescence and the potential therapeutic role of senolytics in the heart

Abstract

Cellular senescence in cardiomyocytes, characterized by cell cycle arrest, resistance to apoptosis, and the senescence-associated secretory phenotype, occurs during aging and in response to various stresses, such as hypoxia/reoxygenation, ischemia/reperfusion, myocardial infarction (MI), pressure overload, doxorubicin treatment, angiotensin II, diabetes, and thoracic irradiation. Senescence in the heart has both beneficial and detrimental effects. Premature senescence of myofibroblasts has salutary effects during MI and pressure overload. On the other hand, persistent activation of senescence in cardiomyocytes precipitates cardiac dysfunction and adverse remodeling through paracrine mechanisms during MI, myocardial ischemia/reperfusion, aging, and doxorubicin-induced cardiomyopathy. Given the adverse roles of senescence in many conditions, specific removal of senescent cells, i.e., senolysis, is of great interest. Senolysis can be achieved using senolytic drugs (such as Navitoclax, Dasatinib, and Quercetin), pharmacogenetic approaches (including INK-ATTAC and AP20187, p16-3MR and Ganciclovir, p16 ablation, and p16-LOX-ATTAC and Cre), and immunogenetic interventions (CAR T cells or senolytic vaccination). In order to enhance the specificity and decrease the off-target effects of senolytic approaches, investigation into the mechanisms through which cardiomyocytes develop and/or maintain the senescent state is needed.

Keywords

Aging / senescence / senescence-associated secretory phenotype / senolysis

References

[1] Li H,Rhee J,Roh JD.Targeting age-related pathways in heart failure.Circ Res2020;126:533-51 PMCID:PMC7041880

[2] López-Otín C,Partridge L,Kroemer G.Hallmarks of aging: an expanding universe.Cell2023;186:243-78

[3] Campisi J.Aging, cellular senescence, and cancer.Annu Rev Physiol2013;75:685-705 PMCID:PMC4166529

[4] Gorgoulis V,Alimonti A.Cellular senescence: defining a path forward.Cell2019;179:813-27

[5] Mehdizadeh M,Thorin E,Nattel S.The role of cellular senescence in cardiac disease: basic biology and clinical relevance.Nat Rev Cardiol2022;19:250-64

[6] Shimizu I.Cellular senescence in cardiac diseases.J Cardiol2019;74:313-9

[7] Anderson R,Maggiorani D.Length-independent telomere damage drives post-mitotic cardiomyocyte senescence.EMBO J2019;38:e100492

[8] Lyu G,Zhang C.TGF-β signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging.Nat Commun2018;9:2560 PMCID:PMC6028646

[9] Zhang FX,Shan QJ.Hypoxia reoxygenation induces premature senescence in neonatal SD rat cardiomyocytes.Acta Pharmacol Sin2007;28:44-51

[10] Dookun E,Redgrave R.Clearance of senescent cells during cardiac ischemia-reperfusion injury improves recovery.Aging Cell2020;19:e13249 PMCID:PMC7576252

[11] Redgrave RE,Booth LK.Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction.NPJ Aging2023;9:15 PMCID:PMC10267185

[12] Salerno N,Scalise M.Pharmacological clearance of senescent cells improves cardiac remodeling and function after myocardial infarction in female aged mice.Mech Ageing Dev2022;208:111740

[13] Lérida-Viso A,Morellá-Aucejo Á.Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice.Pharmacol Res2022;183:106356

[14] Maejima Y,Ito H,Isobe M.Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage.Aging Cell2008;7:125-36

[15] Spallarossa P,Aloi C.Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2.Am J Physiol Heart Circ Physiol2009;297:H2169-81

[16] Sheekey E.p53 in senescence - it’s a marathon, not a sprint.FEBS J2023;290:1212-20

[17] Kim S.Transcriptomic analysis of cellular senescence: one step closer to senescence Atlas.Mol Cells2021;44:136-45 PMCID:PMC8019598

[18] Wechter N,Anerillas C.Single-cell transcriptomic analysis uncovers diverse and dynamic senescent cell populations.Aging2023;15:2824-51 PMCID:PMC10188353

[19] Kale A,Stolzing A,Campisi J.Role of immune cells in the removal of deleterious senescent cells.Immun Ageing2020;17:16 PMCID:PMC7271494

[20] Schloesser D,Sauer J.Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis.J Cell Biol2023;222:e202207097

[21] Ovadya Y.Strategies targeting cellular senescence.J Clin Invest2018;128:1247-54 PMCID:PMC5873866

[22] Mitry MA,Keith BL.Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity.Am J Physiol Cell Physiol2020;318:C380-91 PMCID:PMC7052608

[23] Linders AN,Ovchinnikova ES.Evaluation of senescence and its prevention in doxorubicin-induced cardiotoxicity using dynamic engineered heart tissues.JACC CardioOncol2023;5:298-315 PMCID:PMC10308053

[24] Rouhi L,Zhou Q.Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype.J Cardiovasc Aging2022;2:30 PMCID:PMC9311325

[25] Cui S,Yang F.Postinfarction hearts are protected by premature senescent cardiomyocytes via GATA 4-dependent CCN 1 secretion.J Am Heart Assoc2018;7:e009111 PMCID:PMC6222958

[26] Shibamoto M,Naito AT.Activation of DNA damage response and cellular senescence in cardiac fibroblasts limit cardiac fibrosis after myocardial infarction.Int Heart J2019;60:944-57

[27] Feng T,Kou S.CCN1-induced cellular senescence promotes heart regeneration.Circulation2019;139:2495-8

[28] Sarig R,Bassat E.Transient p53-mediated regenerative senescence in the injured heart.Circulation2019;139:2491-4

[29] Meyer K,Ramanujam D,Sarikas A.Essential role for premature senescence of myofibroblasts in myocardial fibrosis.J Am Coll Cardiol2016;67:2018-28

[30] Sawaki D,Pini M.Visceral adipose tissue drives cardiac aging through modulation of fibroblast senescence by osteopontin production.Circulation2018;138:809-22

[31] Zhu F,Zhang J.Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction.PLoS One2013;8:e74535 PMCID:PMC3770549

[32] Birch J.Senescence and the SASP: many therapeutic avenues.Genes Dev2020;34:1565-76 PMCID:PMC7706700

[33] Chiche A,von Joest M.Injury-induced senescence enables in vivo reprogramming in skeletal muscle.Cell Stem Cell2017;20:407-14.e4

[34] Demaria M,Youssef SA.An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA.Dev Cell2014;31:722-33 PMCID:PMC4349629

[35] Herranz N.Mechanisms and functions of cellular senescence.J Clin Invest2018;128:1238-46 PMCID:PMC5873888

[36] Li T,Ding P.Pathological implication of CaMKII in NF-κB pathway and SASP during cardiomyocytes senescence.Mech Ageing Dev2023;209:111758

[37] Tamamori M,Adachi S,Marumo F.Endothelin-3 induces hypertrophy of cardiomyocytes by the endogenous endothelin-1-mediated mechanism.J Clin Invest1996;97:366-72 PMCID:PMC507026

[38] Park H,Jeong JH,Kim KS.GDF15 contributes to radiation-induced senescence through the ROS-mediated p16 pathway in human endothelial cells.Oncotarget2016;7:9634-44 PMCID:PMC4891072

[39] Rochette L,Zeller M,Vergely C.GDF15 and cardiac cells: current concepts and new insights.Int J Mol Sci2021;22:8889 PMCID:PMC8396208

[40] Rouhi L,Chen SN.Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.Cardiovasc Res2021;117:2377-94 PMCID:PMC8861264

[41] Suarez G.Heart failure and galectin 3.Ann Transl Med2014;2:86 PMCID:PMC4205879

[42] Feng J,Li Y.Versican promotes cardiomyocyte proliferation and cardiac repair.Circulation2024;149:1004-15

[43] Salotti J.Regulation of senescence and the SASP by the transcription factor C/EBPβ.Exp Gerontol2019;128:110752

[44] Felisbino MB,Travers JG.Substrate stiffness modulates cardiac fibroblast activation, senescence, and proinflammatory secretory phenotype.Am J Physiol Heart Circ Physiol2024;326:H61-73

[45] Gevaert AB,Leloup AJ.Endothelial senescence contributes to heart failure with preserved ejection fraction in an aging mouse model.Circ Heart Fail2017;10:e003806

[46] Krishnamurthy J,Ramsey MR.Ink4a/Arf expression is a biomarker of aging.J Clin Invest2004;114:1299-307

[47] Kirkland JL.Senolytic drugs: from discovery to translation.J Intern Med2020;288:518-36 PMCID:PMC7405395

[48] Wang E.Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved.Cancer Res1995;55:2284-92

[49] Zhu Y,Pirtskhalava T.The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs.Aging Cell2015;14:644-58

[50] Lindauer M.Dasatinib.Recent Results Cancer Res2018;212:29-68

[51] Konecny GE,Dering J.Activity of the multikinase inhibitor dasatinib against ovarian cancer cells.Br J Cancer2009;101:1699-708 PMCID:PMC2778533

[52] Bruning A.Inhibition of mTOR signaling by quercetin in cancer treatment and prevention.Anticancer Agents Med Chem2013;13:1025-31

[53] Gu Y,Alvino VV.The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice.Cardiovasc Diabetol2023;22:214 PMCID:PMC10436421

[54] Elmadani M,Mattila O.Dasatinib targets c-Src kinase in cardiotoxicity.Toxicol Rep2023;10:521-8 PMCID:PMC10160240

[55] Chang J,Shao L.Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.Nat Med2016;22:78-83 PMCID:PMC4762215

[56] Jia K,Liu A.Senolytic agent navitoclax inhibits angiotensin II-induced heart failure in mice.J Cardiovasc Pharmacol2020;76:452-60

[57] Walaszczyk A,Redgrave R.Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction.Aging Cell2019;18:e12945 PMCID:PMC6516151

[58] de Vos S,Friedberg JW.Safety and efficacy of navitoclax, a BCL-2 and BCL-X_L inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study.Leuk Lymphoma2021;62:810-8 PMCID:PMC9257998

[59] Escriche-Navarro B,Sancenón F,Martínez-Máñez R.A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells.Acta Biomater2024;176:405-16

[60] Omori S,Johmura Y.Generation of a p16 reporter mouse and its use to characterize and target p16^high cells in vivo.Cell Metab2020;32:814-28.e6

[61] Wang B,Gasek NS.An inducible p21-Cre mouse model to monitor and manipulate p21-highly-expressing senescent cells in vivo.Nat Aging2021;1:962-73 PMCID:PMC8746571

[62] Baker DJ,Tchkonia T.Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.Nature2011;479:232-6 PMCID:PMC3468323

[63] Farr JN,Doolittle ML.Local senolysis in aged mice only partially replicates the benefits of systemic senolysis.J Clin Invest2023;133:e162519 PMCID:PMC10104901

[64] Amor C,Leibold J.Senolytic CAR T cells reverse senescence-associated pathologies.Nature2020;583:127-32 PMCID:PMC7583560

[65] Suda M,Katsuumi G.Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice.Nat Aging2021;1:1117-26

[66] Tasdemir N.Senescent cells spread the word: non-cell autonomous propagation of cellular senescence.EMBO J2013;32:1975-6 PMCID:PMC3715860